Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience  G.L. Pavoni, M. Giannella, M. Falcone, L.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli, G. L
L. Boyanova  Clinical Microbiology and Infection 
P. Melin  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy  J. Cobo, L. Garcia San Miguel, G. Euba,
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
Leucocyte esterase, glucose and C-reactive protein in the diagnosis of prosthetic joint infections: a prospective study  E. De Vecchi, F. Villa, M. Bortolin,
Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy  J. Cobo, L. Garcia San Miguel, G. Euba,
Retrospective study of CMV retinitis in patients with AIDS
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
J. Bodilsen, C. T. Brandt, A. Sharew, M. Dalager-Pedersen, T
Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study  M.R. Berndsen,
Metagenomics and probiotics
Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy  D. Nathwani, J.-J.
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
The practice of travel medicine in Europe
Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study  V.
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Clinical infection services—the Leiden experience
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre  R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli 
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Carratalà J.   Clinical Microbiology and Infection 
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection  A. Russo, M. Falcone, M. Fantoni, R. Murri,
Presentation transcript:

Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience  G.L. Pavoni, M. Giannella, M. Falcone, L. Scorzolini, M. Liberatore, B. Carlesimo, P. Serra, M. Venditti  Clinical Microbiology and Infection  Volume 10, Issue 9, Pages 831-837 (September 2004) DOI: 10.1111/j.1469-0691.2004.00928.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Clinical outcome of conservative medical therapy in 34 prosthetic joint infections. IER, improvement with early relapse; ILR, improvement with late relapse; INR, improvement with no relapse; INER, improvement with no early relapse; ICST, improvement with continued suppressive therapy (CST); LAL, late aseptic loosening. Clinical Microbiology and Infection 2004 10, 831-837DOI: (10.1111/j.1469-0691.2004.00928.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.